These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23790811)

  • 1. Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis.
    Richieri R; Guedj E; Michel P; Loundou A; Auquier P; Lançon C; Boyer L
    J Affect Disord; 2013 Oct; 151(1):129-35. PubMed ID: 23790811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
    Janicak PG; Nahas Z; Lisanby SH; Solvason HB; Sampson SM; McDonald WM; Marangell LB; Rosenquist P; McCall WV; Kimball J; O'Reardon JP; Loo C; Husain MH; Krystal A; Gilmer W; Dowd SM; Demitrack MA; Schatzberg AF
    Brain Stimul; 2010 Oct; 3(4):187-99. PubMed ID: 20965447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
    Solvason HB; Husain M; Fitzgerald PB; Rosenquist P; McCall WV; Kimball J; Gilmer W; Demitrack MA; Lisanby SH
    Brain Stimul; 2014; 7(2):219-25. PubMed ID: 24332384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial direct current stimulation (tDCS) for preventing major depressive disorder relapse: Results of a 6-month follow-up.
    Aparicio LVM; Rosa V; Razza LM; Sampaio-Junior B; Borrione L; Valiengo L; Lotufo PA; Benseñor IM; Fraguas R; Moffa AH; Gattaz WF; Brunoni AR
    Depress Anxiety; 2019 Mar; 36(3):262-268. PubMed ID: 30637889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study.
    Philip NS; Dunner DL; Dowd SM; Aaronson ST; Brock DG; Carpenter LL; Demitrack MA; Hovav S; Janicak PG; George MS
    Brain Stimul; 2016; 9(2):251-7. PubMed ID: 26708778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse prevention (RP) TMS.
    Pridmore S; May T
    Brain Stimul; 2018; 11(6):1391-1392. PubMed ID: 30143418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.
    Harel EV; Rabany L; Deutsch L; Bloch Y; Zangen A; Levkovitz Y
    World J Biol Psychiatry; 2014 May; 15(4):298-306. PubMed ID: 22313023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
    Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
    Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 6-month follow-up study on response and relapse rates following an acute trial of repetitive transcranial magnetic stimulation in patients with major depression.
    Arici C; Benatti B; Cafaro R; Cremaschi L; Degoni L; Pozzoli S; Oldani L; Molteni L; Giorgetti F; Priori A; Viganò C; Dell'Osso B
    CNS Spectr; 2022 Feb; 27(1):93-98. PubMed ID: 32883389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustered repetitive transcranial magnetic stimulation for the prevention of depressive relapse/recurrence: a randomized controlled trial.
    Wang HN; Wang XX; Zhang RG; Wang Y; Cai M; Zhang YH; Sun RZ; Guo L; Qiao YT; Liu JC; He H; Wang ZH; Wan YC; Tan QR; Zhang ZJ
    Transl Psychiatry; 2017 Dec; 7(12):1292. PubMed ID: 29249805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of frontal cerebral blood volume during transcranial magnetic stimulation in depression is related to treatment effectiveness: A pilot study with near-infrared spectroscopy.
    Shinba T; Kariya N; Matsuda S; Matsuda H; Obara Y
    Psychiatry Clin Neurosci; 2018 Aug; 72(8):602-610. PubMed ID: 29774621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial magnetic stimulation maintenance as a substitute for maintenance electroconvulsive therapy: a case series.
    Cristancho MA; Helmer A; Connolly R; Cristancho P; O'Reardon JP
    J ECT; 2013 Jun; 29(2):106-8. PubMed ID: 23519219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral activation therapy during transcranial magnetic stimulation for major depressive disorder.
    Russo GB; Tirrell E; Busch A; Carpenter LL
    J Affect Disord; 2018 Aug; 236():101-104. PubMed ID: 29723763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data.
    Demitrack MA; Thase ME
    Psychopharmacol Bull; 2009; 42(2):5-38. PubMed ID: 19629020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
    Carpenter LL; Janicak PG; Aaronson ST; Boyadjis T; Brock DG; Cook IA; Dunner DL; Lanocha K; Solvason HB; Demitrack MA
    Depress Anxiety; 2012 Jul; 29(7):587-96. PubMed ID: 22689344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of repetitive transcranial magnetic stimulation as a maintenance treatment in patients with major depression.
    Haesebaert F; Moirand R; Schott-Pethelaz AM; Brunelin J; Poulet E
    World J Biol Psychiatry; 2018 Feb; 19(1):74-78. PubMed ID: 27807990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional magnetic resonance imaging study of the effects of low frequency right prefrontal transcranial magnetic stimulation in depression.
    Fitzgerald PB; Sritharan A; Daskalakis ZJ; de Castella AR; Kulkarni J; Egan G
    J Clin Psychopharmacol; 2007 Oct; 27(5):488-92. PubMed ID: 17873682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sertraline versus electrical current therapy for treating depression clinical study (select-TDCS): results of the crossover and follow-up phases.
    Valiengo L; Benseñor IM; Goulart AC; de Oliveira JF; Zanao TA; Boggio PS; Lotufo PA; Fregni F; Brunoni AR
    Depress Anxiety; 2013 Jul; 30(7):646-53. PubMed ID: 23625554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Repetitive transcranial magnetic stimulation in major depression: response factor].
    Dumas R; Padovani R; Richieri R; Lançon C
    Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.